iSpecimen Inc (ISPC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, iSpecimen Inc (ISPC) has a cash flow conversion efficiency ratio of -0.397x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-689.62K) by net assets ($1.74 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see iSpecimen Inc stock valuation for the company's overall valuation and market capitalisation.
iSpecimen Inc - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how iSpecimen Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
iSpecimen Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of iSpecimen Inc ranked by their cash flow conversion efficiency. See debt repayment capacity of iSpecimen Inc to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Forza X1 Inc
NASDAQ:FRZA
|
-0.075x |
|
NEOMETALS LTD SP.ADS/10
F:9R91
|
N/A |
|
Haffner Energy SA
PA:ALHAF
|
-0.330x |
|
Niki BioSolutions, Inc.
NASDAQ:NIKI
|
-0.039x |
|
Empire Metals Limited
LSE:EEE
|
-0.267x |
|
TRU PRECIOUS METALS CORP.
F:706
|
0.054x |
|
CubicFarm Systems Corp
V:CUB
|
0.012x |
|
GLOBAL UAV TECHS
F:YAB
|
0.036x |
Annual Cash Flow Conversion Efficiency for iSpecimen Inc (2018–2025)
The table below shows the annual cash flow conversion efficiency of iSpecimen Inc from 2018 to 2025. View ISPC share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $3.09 Million | $-4.24 Million | -1.373x | +44.98% |
| 2024-12-31 | $3.31 Million | $-8.26 Million | -2.496x | -318.63% |
| 2023-12-31 | $9.74 Million | $-5.81 Million | -0.596x | -108.13% |
| 2022-12-31 | $20.31 Million | $-5.82 Million | -0.286x | +20.01% |
| 2021-12-31 | $29.79 Million | $-10.67 Million | -0.358x | -3487.29% |
| 2020-12-31 | $-27.28 Million | $-288.38K | 0.011x | -91.04% |
| 2019-12-31 | $-22.72 Million | $-2.68 Million | 0.118x | -18.96% |
| 2018-12-31 | $-18.42 Million | $-2.68 Million | 0.146x | -- |
About iSpecimen Inc
iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have ac… Read more